beta

ABIO

ARCA biopharma Inc.

Abio

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.

Market Cap: 21.7 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.arcabiopharma.com

Shares Outstanding: 11.8 Million

Float: 11.3 Million

Dividend: 0.0 (0.0%)

Beta: 1.211096

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 116 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1829 trading days

From: 2013-01-31 To: 2019-10-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-09-04 7.0 1.0 7.0
2013-03-05 6.0 1.0 6.0
Data provided by IEX Cloud